ArticleBlood vessels, thrombosis & hemostasis2025
Prevalence of cardiovascular risk factors in persons with venous thromboembolism aged 50 years or younger.
Article in Blood vessels, thrombosis & hemostasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The risk of cardiovascular disease (CVD) is elevated in individuals with a history of venous thromboembolism (VTE). It is uncertain whether younger patients, aged ≤50 years, have an increased prevalence of potentially modifiable CVD risk factors, which could be targeted for prevention. We aimed to estimate the prevalence of potentially modifiable CVD risk factors (ie, overweight/obesity, smoking, alcohol use, physical inactivity, hypertension, diabetes mellitus, and dyslipidemia) in persons aged ≤50 years with a history of VTE (cases) and compare with those without VTE (controls). Using data from the Multiple Environmental and Genetic Assessment of risk factors for venous thrombosis case-control study comprising 2627 case patients with first VTE and 1908 random digit dialing control patients, all aged ≤50 years, we estimated the prevalence of risk factors. Analyses were stratified by sex and were performed separately for unprovoked and provoked events. The prevalence of hypertension, diabetes, dyslipidemia, and excessive alcohol intake was low and similar between case and control patients. The prevalence of overweight and obesity, sedentary behavior, and current smoking was higher in case than control patients. When stratified for sex, obesity was highest in women: 24.9% in case vs 9.9% in control patients. Sedentary behavior was more common in case patients than control patients: women, 57.8% vs 41.1%; and men, 48.7% vs 41.5%, respectively. In persons aged ≤50 years with recent VTE, the prevalence of hypertension, diabetes mellitus, dyslipidemia, and alcohol intake was similar to that of control patients from the general population, suggesting limited benefits from screening these factors in young patients with VTE. Weight reduction and smoking cessation strategies are key targets for CVD prevention.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.